HBsAg prevalence among children (5 to 9 years old) and mothers (15 to 45 years old) in Lao PDR by selected background characteristics.

1<p>Transportation to the nearest health facility, ² Time to the nearest health facility, ³ Mothers' completed education, ⁴ Family head's occupation.</p

Unadjusted and adjusted odds ratio for being HBsAg positive among children from five to nine years old in Lao PDR by selected background characteristics.

<p>Unadjusted and adjusted odds ratio for being HBsAg positive among children from five to nine years old in Lao PDR by selected background characteristics.</p

HBsAg prevalence among children (5 to 9 years old) and mothers (15 to 45 years old).

<p>HBsAg prevalence among children (5 to 9 years old) and mothers (15 to 45 years old).</p

Unadjusted and adjusted odds ratio for being HBsAg positive among mothers from 15 to 45 years old in Lao PDR by selected background characteristics.

<p>Unadjusted and adjusted odds ratio for being HBsAg positive among mothers from 15 to 45 years old in Lao PDR by selected background characteristics.</p

Stability testing of reconstituted measles and rubella combination vaccines.

<p>After incubation of reconstituted vaccines at 4°C (A), 25°C (B), or 35°C (C), titres of measles and rubella viruses in the vaccines were measured by plaque assays. Filled squares and open circles indicate titres of measles and rubella viruses, respectively. Means of three vials are shown. Error bars indicate standard deviations.</p

Best-fitting values of the force of infection in Lao PDR before the 2011 SIA among participants aged < 15 and ≥ 15 years, obtained by the selected best-fitting model (model B) for different assumptions about the reduction in the force of infection after the SIA, and CRS incidence per 100,000 live births among women aged 15–44 years after weighting by the number of live births occurring among women in different maternal age groups.

<p>Best-fitting values of the force of infection in Lao PDR before the 2011 SIA among participants aged < 15 and ≥ 15 years, obtained by the selected best-fitting model (model B) for different assumptions about the reduction in the force of infection after the SIA, and CRS incidence per 100,000 live births among women aged 15–44 years after weighting by the number of live births occurring among women in different maternal age groups.</p

Stability testing of freeze-dried measles and rubella combination vaccines.

<p>After incubation of freeze-dried vaccines at 4°C (A), 25°C (B), or 35°C (C), titres of measles and rubella viruses in the vaccines were measured by plaque assays. Filled squares and open circles indicate titres of measles and rubella viruses, respectively. Means of three vials are shown. Error bars indicate standard deviations.</p

Measles IgG seroprevalence measured by ELISA in different age groups from representative populations of Lao PDR, 2014.

<p>*An ELISA value of 120 mIU/mL was considered positive. †Individuals 5–14 years old and 15–21 years old were among the targeted age groups of supplementary immunization activities conducted in 2011 using the MR combination vaccine with coverage of 97%. Their IgG prevalence was estimated to be 86.8% (95% CI: 83.0–90.6).</p

Comparison between the predictions of age-specific percentage seronegative, obtained using the best-fitting catalytic model and the observed data.

<p>Bars reflect 95% confidence intervals of the observed data. Lines reflect predictions from the best-fitting model.</p

Reported coverage of routine immunization and supplementary immunization activities with measles containing vaccine by age at the survey in Lao PDR, 2014^*.

<p>Reported coverage of routine immunization and supplementary immunization activities with measles containing vaccine by age at the survey in Lao PDR, 2014^{<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0194931#t001fn001" target="_blank">*</a>}.</p